Financial Perspectives’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial Perspectives’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$143K	Sell	189 -2	-1%	-$1.51K	0.03%	212
2026 Q2	$119K	Hold	191	–	–	0.03%	227
2026 Q1	$148K	Sell	191 -2	-1%	-$1.53K	0.04%	196
2025 Q4	$149K	Hold	193	–	–	0.04%	188
2025 Q3	$109K	Hold	193	–	–	0.03%	223
2025 Q2	$101K	Hold	193	–	–	0.03%	219
2025 Q1	$122K	Hold	193	–	–	0.04%	192
2024 Q4	$137K	Buy	193 +19	+11%	+$15.9K	0.05%	177
2024 Q3	$183K	Hold	174	–	–	0.06%	146
2024 Q2	$183K	Hold	174	–	–	0.07%	142
2024 Q1	$167K	Hold	174	–	–	0.06%	151
2023 Q4	$153K	Hold	174	–	–	0.06%	158
2023 Q3	$143K	Hold	174	–	–	0.07%	153
2023 Q2	$125K	Hold	174	–	–	0.06%	160
2023 Q1	$143K	Hold	174	–	–	0.07%	147
2022 Q4	$126K	Hold	174	–	–	0.06%	154
2022 Q3	$120K	Hold	174	–	–	0.07%	155
2022 Q2	$103K	Hold	174	–	–	0.06%	168
2022 Q1	$122K	Hold	174	–	–	0.06%	169
2021 Q4	$110K	Hold	174	–	–	0.05%	166
2021 Q3	$105K	Hold	174	–	–	0.05%	169
2021 Q2	$97.2K	Hold	174	–	–	0.05%	189
2021 Q1	$82.3K	Hold	174	–	–	0.04%	191
2020 Q4	$84.1K	Buy	174 +94	+118%	+$50.7K	0.05%	182
2020 Q3	$44.8K	Buy	80 +12	+18%	+$7.28K	0.03%	209
2020 Q2	$42.4K	Hold	68	–	–	0.03%	198
2020 Q1	$33.2K	Buy	+68	New	+$28K	0.03%	194

Other funds holding REGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Financial Perspectives's REGN Position: Q3 2026 in Review

Financial Perspectives reduced its Regeneron Pharmaceuticals (REGN) stake by 1% in Q3 2026, selling an estimated $1.51K and leaving 189 shares worth $143K. The position accounts for 0.03% of the portfolio, ranked #212.

Financial Perspectives first reported a position in REGN in Q1 2020 and has held it in 27 quarters since. The position peaked at $183K in Q3 2024. 755 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Financial Perspectives held 189 shares of Regeneron Pharmaceuticals worth $143K as of Q3 2026.
Financial Perspectives sold 2 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $1.51K.
Regeneron Pharmaceuticals made up 0.03% of Financial Perspectives's portfolio in Q3 2026, its #212 holding.
Financial Perspectives first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
Financial Perspectives's Regeneron Pharmaceuticals position peaked at $183K in Q3 2024.
755 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Financial Perspectives's 13F filing for Q3 2026, filed 3 Nov 2026.